Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
738
datasets available to search
ShareScore release 0.7.1
Dataset results
738 results for “Adverse events”
Variation in Detected Adverse Events using Trigger Tools: A Systematic Review and Meta-Analysis
<p>Raw data sets for the meta-analysis.</p> <p>Data collection file with all the information extracted from the included studies.</p> <p>QAT file with the information from the quality assessment tool (QAT) for all included studies.</p> <p>ReadMe with information on data sets and updates.</p> <p>Codebooks for both data sets.</p>
Supplementary file 30 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 30: Proportion of participants on methylphenidate with asthenia and fatigue </p>
Supplementary file 37 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 37: Proportion of participants on methylphenidate with restlessness and agitation</p>
Supplementary file 66 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 66: Proportion of participants on methylphenidate with gastrointestinal adverse events</p>
Supplementary file 55 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 55: Proportion of participants on methylphenidate with upper respiratory tract infection</p>
Supplementary file 11 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 11: Proportion of participants on methylphenidate with respiratory, thoracic and mediastinal disorders</p>
Supplementary file 22 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 22: Proportion of participants on methylphenidate with difficulty falling asleep</p>
Supplementary file 33 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 33: Proportion of participants on methylphenidate with involuntary movements </p>
Supplementary file 41 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 41: Proportion of participants on methylphenidate with taciturnity (‘talking too little’)</p>
Supplementary file 32 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 32 Proportion of participants on methylphenidate with increased need to sleep</p>
Supplementary file 44 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 44: Proportion of participants on methylphenidate with ’zombie-like’ demeanour</p>
Supplementary file 43 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 43: Proportion of participants on methylphenidate with isolation and lack of interest in others</p>
Incidence and Characteristics of Adverse Events in Paediatric Inpatient Care: a Systematic Review and Meta-Analysis
<p>This is the open data repository for the connected systematic review and meta-analysis.</p> <p>Data sets for the meta-analysis.</p> <p>Data collection file with all the information extracted from the included studies.</p> <p>QAT file with the information from the quality assessment tool (QAT) for all included studies.</p> <p>ReadMe with information on data sets and updates.</p> <p>Codebooks for data sets.</p> <p>R Code for the analysis</p>
Supplementary file 48 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 48: Proportion of patients on methylphenidate with agitation</p>
Supplementary file 51 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 51: Proportion of patients on methylphenidate with sleep disorder</p>
Supplementary file 47 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 47: Proportion of patients on methylphenidate with isolation</p>
Supplementary file ROBINS-I Risk of Bias table in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies.
<p>ROBINS-I Risk og Bias Table</p>
Supplementary file 19 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 19 Proportion of patients on methylphenidate with asthenia </p>
Supplementary file 13 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 13: Proportion of patients on methylphenidate with tachycardia </p>
Supplementary file 80 in Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of possible adverse events in non-randomised studies
<p>Supplementary file 80: Proportion of participants on methylphenidate with rhinitis</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.